Information:
Fel:
ID
27901
Beskrivning
High Dose Ribavirin in the Treatment of Chronic Hepatitis C; ODM derived from: https://clinicaltrials.gov/show/NCT00944684
Länk
https://clinicaltrials.gov/show/NCT00944684
Nyckelord
Versioner (1)
- 2017-12-04 2017-12-04 -
Rättsinnehavare
See clinicaltrials.gov
Uppladdad den
4 december 2017
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Chronic Hepatitis C NCT00944684
Eligibility Chronic Hepatitis C NCT00944684
- StudyEvent: Eligibility
Similar models
Eligibility Chronic Hepatitis C NCT00944684
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Age
Item
male and female patients aged 18-65 years
boolean
C0001779 (UMLS CUI [1])
Elevated liver enzymes level
Item
elevated liver enzymes levels
boolean
C0857093 (UMLS CUI [1])
Compensated liver disease
Item
compensated liver disease
boolean
C3839044 (UMLS CUI [1])
Liver Histology METAVIR Fibrosis Score
Item
available liver histology confirming metavir f2 fibrosis
boolean
C0023884 (UMLS CUI [1,1])
C0344441 (UMLS CUI [1,2])
C3897040 (UMLS CUI [1,3])
C0344441 (UMLS CUI [1,2])
C3897040 (UMLS CUI [1,3])
Informed Consent
Item
written consent to participation
boolean
C0021430 (UMLS CUI [1])
Age
Item
age <18, >65
boolean
C0001779 (UMLS CUI [1])
Ribavirin
Item
prior ribavirin treatment
boolean
C0035525 (UMLS CUI [1])
Intolerance to Ribavirin | Intolerance to pegylated interferon alfa | Intolerance to Erythropoietin
Item
intolerance towards ribavirin, pegifn or erythropoetin
boolean
C1744706 (UMLS CUI [1,1])
C0035525 (UMLS CUI [1,2])
C1744706 (UMLS CUI [2,1])
C0907160 (UMLS CUI [2,2])
C1744706 (UMLS CUI [3,1])
C0014822 (UMLS CUI [3,2])
C0035525 (UMLS CUI [1,2])
C1744706 (UMLS CUI [2,1])
C0907160 (UMLS CUI [2,2])
C1744706 (UMLS CUI [3,1])
C0014822 (UMLS CUI [3,2])
Pregnancy | Breast Feeding
Item
pregnancy or breast feeding
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0006147 (UMLS CUI [2])
Cardiovascular Disease | Lung disease
Item
relevant cardiovascular or pulmonary disease
boolean
C0007222 (UMLS CUI [1])
C0024115 (UMLS CUI [2])
C0024115 (UMLS CUI [2])
Renal Insufficiency | Creatinine clearance measurement
Item
kidney insufficiency (creatinine clearance <50ml/min)
boolean
C1565489 (UMLS CUI [1])
C0373595 (UMLS CUI [2])
C0373595 (UMLS CUI [2])
HIV coinfection | HBV coinfection
Item
coinfection with hiv or hepatitis b virus
boolean
C4062778 (UMLS CUI [1])
C2242656 (UMLS CUI [2])
C2242656 (UMLS CUI [2])
Comorbidity Hepatic | Hemochromatosis | Hepatolenticular Degeneration | Autoimmune Diseases
Item
hepatic comorbidities (hemochromatosis, wilson's disease, autoimmune disorders)
boolean
C0009488 (UMLS CUI [1,1])
C0205054 (UMLS CUI [1,2])
C0018995 (UMLS CUI [2])
C0019202 (UMLS CUI [3])
C0004364 (UMLS CUI [4])
C0205054 (UMLS CUI [1,2])
C0018995 (UMLS CUI [2])
C0019202 (UMLS CUI [3])
C0004364 (UMLS CUI [4])
Alcohol consumption U/day
Item
alcohol consumption > 40g/day
boolean
C0001948 (UMLS CUI [1,1])
C0456683 (UMLS CUI [1,2])
C0456683 (UMLS CUI [1,2])
Mental disorders
Item
psychiatric disorders
boolean
C0004936 (UMLS CUI [1])
Malignant Neoplasms | Exception Basal cell carcinoma
Item
malignancy (except for basalioma)
boolean
C0006826 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0007117 (UMLS CUI [2,2])
C1705847 (UMLS CUI [2,1])
C0007117 (UMLS CUI [2,2])
Illicit drug use
Item
active consumption of illicit drugs
boolean
C0281875 (UMLS CUI [1])
Study Subject Participation Status
Item
participation in another trial shorter than 3 months prior to inclusion
boolean
C2348568 (UMLS CUI [1])
Informed Consent Lacking
Item
lack of consent
boolean
C0021430 (UMLS CUI [1,1])
C0332268 (UMLS CUI [1,2])
C0332268 (UMLS CUI [1,2])